EFFECTOR THERAPEUTICS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch EFTR and buy or sell other stocks, ETFs, and their options commission-free!About EFTR
eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2).
CEOStephen T. Worland
CEOStephen T. Worland
Employees15
Employees15
HeadquartersSolana Beach, California
HeadquartersSolana Beach, California
Founded2012
Founded2012
Employees15
Employees15
EFTR Key Statistics
Market cap12.92K
Market cap12.92K
Price-Earnings ratio-12.57
Price-Earnings ratio-12.57
Dividend yield—
Dividend yield—
Average volume2.96M
Average volume2.96M
High today$0.001
High today$0.001
Low today$0.0002
Low today$0.0002
Open price$0.001
Open price$0.001
Volume282.00
Volume282.00
52 Week high$1.48
52 Week high$1.48
52 Week low$0.0002
52 Week low$0.0002
Stock Snapshot
EFFECTOR THERAPEUTICS(EFTR) stock is priced at $0.00, giving the company a market capitalization of 12.92K. It carries a P/E multiple of -12.57.
On 2026-01-19, EFFECTOR THERAPEUTICS(EFTR) stock traded between a low of $0.00 and a high of $0.00. Shares are currently priced at $0.00, which is 0.0% above the low and -80.0% below the high.
EFFECTOR THERAPEUTICS(EFTR) shares are trading with a volume of 282, against a daily average of 2.96M.
In the last year, EFFECTOR THERAPEUTICS(EFTR) shares hit a 52-week high of $1.48 and a 52-week low of $0.00.
In the last year, EFFECTOR THERAPEUTICS(EFTR) shares hit a 52-week high of $1.48 and a 52-week low of $0.00.
People also own
Based on the portfolios of people who own EFTR. This list is generated using Robinhood data, and it’s not a recommendation.